Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01363505 · ClinicalTrials.gov registry record
Bladder Pressure Predicting Renal Failure in Critically Ill Patients as Compared to Hemodynamic Parameters
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 16
- Enrollment target
NCT01363505: Completed study, sponsored by Northwell Health.
NCT01363505 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 16 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01363505 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
Studies have shown that more than 30% of the overall acute decompensated heart failure (ADHF) patients develop renal dysfunction. Several studies have tried to find a correlation between hemodynamic Parameters (blood pressure , heart rate, central venous pressure CVP) and worsening of renal function in acute decompensated heart failure patients. Results showed that there were no correlation between baseline hemodynamics or change in hemodynamics and worsening of renal function. Another study showed that intra-abdominal pressure (IAP) measuring was a better corollary to renal failure status then measuring cardiovascular hemodynamics using pulmonary artery catheterization in ADHF patients.. An increased IAP was associated with worse renal function and that level of IAP far below abdominal compartment syndrome may adversely affect renal function in patients with ADHF.
Primary Outcome
IAP measurements will be recorded concomitantly with renal indices. Correlations will be made in regard to pressure measurements and worsening renal function.
Interventions
- DEVICE BARD® Intra-abdominal Pressure monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2011-05 |
| Est. Completion | 2013-04 |
What the finished NCT01363505 record still lists
NCT01363505 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which BARD® Intra-abdominal Pressure monitor is the first listed.
NCT01363505 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01363505 about?
NCT01363505 is a clinical study titled "Bladder Pressure Predicting Renal Failure in Critically Ill Patients as Compared to Hemodynamic Parameters". Studies have shown that more than 30% of the overall acute decompensated heart failure (ADHF) patients develop renal dysfunction. Several studies have tried to find a correlation between hemodynamic Parameters (blood pressure , heart rate, central venous pressure CVP) and worsening of renal functio...
What is the current status of trial NCT01363505?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2011-05. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01363505?
The interventions under investigation include: BARD® Intra-abdominal Pressure monitor (DEVICE).
Who is sponsoring clinical trial NCT01363505?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia